| Name | Title | Contact Details |
|---|
Nanoscale Combinatorial Synthesis, Inc. is a Menlo Park, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Modern Vascular is a group of healthcare companies headquartered in Phoenix, AZ. Modern Vascular clinics specialize in the treatment of peripheral artery disease (PAD) through infrapopliteal, inframalleolar, and pedal endovascular arterial reconstruction. Most patients report reduced pain, rapid wound healing, and a better quality of life post procedure. Modern Vascular procedures are also an important step in avoiding future limb amputation and extending life expectancy in diabetic, cardiovascular, and peripheral artery disease patients. Modern Vascular now operates and manages thirteen clinics across AZ, CO, MS, NM, TX, VA
Founded in 2019, Wellvana is a company designed to support independent physicians and help them thrive in their transition to value-based care. With a mission of creating a national footprint of high performing, locally narrow networks, Wellvana aims to deliver high quality and highly efficient healthcare services while contracting on behalf of and migrating physicians towards risk-based reimbursement methodologies. Wellvana provides the resources, experience, and leadership to allow physicians to practice effectively, achieve work life balance, and benefit from risk-based revenue models, while respecting cultural, regional, and individual practice uniqueness.
AIT Laboratories is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.
Hemispherx Biopharma, Inc., a specialty pharmaceutical company, engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders. Its products include Ampligen, which is under clinical development for the treatment of Chronic Fatigue Syndrome, Hepatitis B, human immunodeficiency virus (HIV), renal cell carcinoma, and malignant melanoma; Alferon N Injection, an injectable formulation of natural alpha interferon for the treatment of certain categories of genital warts; and Alferon LDO, a low-dose oral liquid formulation of natural alpha interferon for the treatment of influenza and other emerging viral diseases. Hemispherx Biopharma, Inc. was founded in 1990 and is headquartered in Philadelphia, Pennsylvania.